Clinical Trials Sponsored by PegBio Co., Ltd.

Total 10243 results

PegBio Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects

Obesity
PegBio Co., Ltd.

Recruiting

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China, Taiwan, Hong Kong
PegBio Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

Obesity

China
PegBio Co., Ltd.

Completed

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

Type2 Diabetes Mellitus

United States
PegBio Co., Ltd.

Completed

Continuous Multiple Dose PB-119 Injection in Health Volunteers

Type2 Diabetes Mellitus

China
PegBio Co., Ltd.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy

Type 2 Diabetes Mellitus

China
PegBio Co., Ltd.

Completed

Clinical Trial for PB-119 in Healthy Subjects (Phase I)

Type II Diabetes

China
PegBio Co., Ltd.

Not yet recruiting

Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function

Type2Diabetes

China
PegBio Co., Ltd.

Completed

Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects (PB119)

Type 2 Diabetes Mellitus (T2DM)

China
PegBio Co., Ltd.

Completed

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

China
PegBio Co., Ltd.

Completed

Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus

China
PegBio Co., Ltd.

Completed

Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

China
PegBio Co., Ltd.
Covance

Completed

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)

United States
PegBio Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Type 2 Diabetes Mellitus

China
PegBio Co., Ltd.
Covance

Completed

A Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study

Healthy Subjects

United States
Hiroshima University
NewBio Enterprise Co., ltd.

Completed

Effect of the Extract of the Flour Fermented With Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose

Prediabetes

Japan
Huons Co., Ltd.
Humedix Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

Nasolabial FOLD

Korea, Republic of
InventisBio Co., Ltd
InxMed (Shanghai) Co., Ltd.

Recruiting

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

Solid Tumor

China
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Terminated

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Pancreatic Neoplasms

Taiwan, Japan, Hong Kong, Singapore, Philippines, Malaysia, Korea, Republic of
InxMed (Shanghai) Co., Ltd.
InventisBio Co., Ltd

Recruiting

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Solid Tumor

China
IlDong Pharmaceutical Co Ltd
YUNOVIA CO.,LTD.

Recruiting

Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Healthy Adult Subjects

Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Recruiting

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

SCCHN

Croatia, Czechia, Hungary, Poland, Russian Federation, Serbia, Taiwan, Ukraine
CHABiotech CO., Ltd
Seoul CRO Co., Ltd.

Completed

Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain

Chronic Low-back Pain | Disc Degeneration

Korea, Republic of
Hyundai Bioland Co., Ltd.
Medipost Co Ltd.

Completed

Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus

Chondral or Osteochondral Lesion of Talus

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.
CliPS Co., Ltd

Completed

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Locally Advanced and Metastatic Pancreatic Cancer

Taiwan, Singapore
Walvax Biotechnology Co., Ltd.
Abogen Biosciences Co. Ltd.; Yuxi Walvax Biotechnology Co., Ltd.

Recruiting

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

COVID-19 | SARS-CoV-2

Indonesia, Mexico
Wuhan BravoVax Co., Ltd.
Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Herpes Zoster
SK Bioscience Co., Ltd.

Completed

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

Varicella

Philippines
Kissei Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.

Completed

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Anemia

Japan
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd

Terminated

Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Mild to Moderate Psoriasis

China
Kuhnil Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.

Terminated

Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer

Gastric Cancer | Gastroesophageal Junction Cancer

Taiwan, Japan, Korea, Republic of
Medipost Co Ltd.
Dong-A Pharmaceutical Co., Ltd.

Completed

Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect

Defect of Articular Cartilage | Degenerative Osteoarthritis

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.
UCB Japan Co. Ltd.

Completed

Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Japan
Daewoong Pharmaceutical Co. LTD.
Bio-alpha Co. LTD.

Completed

Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation

Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation

Korea, Republic of
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Oneness Biotech Co., Ltd.
Microbio Shanghai Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Allergic Asthma

Taiwan
S.Biomedics Co., Ltd.
Yonsei University; Linical Co., Ltd.

Recruiting

Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI (SB-SCI-001)

Spinal Cord Injury, Acute | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C4 Level With Complete Lesion

Korea, Republic of
HanAll BioPharma Co., Ltd.
Daewoong Pharmaceutical Co. LTD.

Completed

A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye (VELOS-3)

Dry Eye

United States
Orient Pharma Co., Ltd.
Orient Europharma Co., Ltd.

Completed

Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

Hypercholesterolemia

Taiwan
HanAll BioPharma Co., Ltd.
Daewoong Pharmaceutical Co. LTD.

Completed

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes (VELOS-2)

Dry Eye

United States
Taiho Pharmaceutical Co., Ltd.
Yakult Honsha Co., LTD

Completed

Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer (SOLAR)

Gastric Cancer

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.
Ono Pharmaceutical Co. Ltd

Completed

Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors

Solid Tumor

Japan
Kissei Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.

Completed

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Anemia

Japan
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Psoriasis

China
DH Bio Co., Ltd.
BTO Pharm. Co., Ltd.

Completed

Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes

Dry Eye Syndromes

Korea, Republic of
Taiho Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.

Completed

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

Colorectal Cancer

Japan
Otsuka Pharmaceutical Co., Ltd.
UCB Japan Co. Ltd.

Completed

Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Japan
Ono Pharmaceutical Co. Ltd
Kyorin Pharmaceutical Co.,Ltd

Completed

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

Overactive Bladder

Japan

3

Subscribe